Pinealon vs VIP (Vasoactive Intestinal Peptide)

A detailed comparison to help you understand the differences and choose the right peptide for your research goals.

Pinealon

Pinealon is a short synthetic peptide developed from research on the pineal gland. It has shown neuroprotective and cognitive-enhancing properties in animal studies.

Full details →

VIP (Vasoactive Intestinal Peptide)

VIP is a 28-amino acid neuropeptide with wide-ranging effects throughout the body. It acts as a neurotransmitter, neuromodulator, and immune regulator with particular importance in gut and lung function.

Full details →

Side-by-Side Comparison

AspectPinealonVIP (Vasoactive Intestinal Peptide)
MechanismPenetrates cell membranes and interacts with DNA to regulate gene expression related to neuronal survival and function. May support pineal gland function and melatonin production.Binds to VPAC1 and VPAC2 receptors to modulate immune responses, regulate circadian rhythms, promote vasodilation, and support barrier function in gut and lungs. Has potent anti-inflammatory effects.
Typical DosageTypical dosing: 10-20mg daily, taken in divided doses. Often used in cycles of 10-20 days.Intranasal: 50-200mcg 1-3 times daily for chronic inflammatory conditions. Some protocols use subcutaneous administration. Dosing varies by condition.
AdministrationCan be taken orally (capsules) or sublingually. Best absorbed on an empty stomach. Often combined with other neuroprotective peptides.Intranasal is most common for inflammatory conditions. Subcutaneous injection also used. Must be stored cold and protected from light.
Side EffectsGenerally well-tolerated. Limited reported side effects. May affect sleep patterns initially.May cause nasal irritation, flushing, headache, or temporary diarrhea. Generally well-tolerated at standard doses.
Best For

What They Have in Common

Both Pinealon and VIP (Vasoactive Intestinal Peptide) are commonly used for:

Key Differences

Unique to Pinealon:

Unique to VIP (Vasoactive Intestinal Peptide):

Ready to Learn More?